Schedule 13G ownership disclosure

TRAVERE THERAPEUTICS INC

Security class unavailable · CUSIP: 89422G107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,142,175
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-23-000194
Form type
SC 13G/A
Filer
GOLDMAN SACHS GROUP INC
CIK
CIK 886982
Filed
Feb 10, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub